News

The KARMA-Dep 2 trial finds ketamine for depression no more effective than placebo in treating hospitalised patients with major depression.

US-RASP has emerged as a promising alternative that maintains sexual function while providing comparable outcomes in urinary symptom relief.

Younger adults with early-onset lung cancer face poorer survival linked to late diagnosis, income, and access to care, highlighting urgent equity needs.

Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

New genetic study links plasma proteins to blood pressure regulation and cardiovascular disease, offering potential targets for heart health therapies.

A new study has identified TRIM56, an E3 ubiquitin ligase, as a key activator of the proto-oncogene Src in hepatocellular carcinoma.

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

This paradoxical effect appears to be context-dependent, influenced by factors such as infection, allergen exposure, and systemic stress.